The Global Pharma Manufacturing Summit has grown into the premier networking opportunity for industry leaders in small molecule and biologic pharmaceutical manufacturing.
Manufacturers are facing increasing pressure to grow and evolve beyond strategies of the past. New technologies, heightened regulatory guidelines, and the oncoming wave of generic products are shaping a new exciting chapter for the industry.
Key themes in this year’s agenda included:
“I enjoyed the event and that the talks were the perfect amount of time to keep your attention.”Tara Davis, QA Sr. Associate I, Biogen Idec
“Worthwhile. Will be recommending to colleagues.” David Henry, Director Industrial Process, Medicago USA Inc.